Navigation Links
Exagen Diagnostics Enters Into Exclusive Agreement With EndoChoice
Date:2/16/2010

ALBUQUERQUE, N.M., Feb. 16 /PRNewswire/ -- Exagen Diagnostics, Inc., a molecular diagnostics laboratory that discovers, develops and markets proprietary genomic tests, today announced an exclusive sales and marketing agreement with EndoChoice, Inc. to promote its diagnostic services to gastroenterologists throughout the United States.

Under the agreement, EndoChoice's experienced, gastroenterology-focused sales force will introduce Exagen's proprietary gene expression tests for the diagnosis of Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS).  Exagen developed these molecular tests through its discovery engine, Coperna®, which identified "gene activity signatures" associated with IBD and IBS.

Scott Glenn, Exagen's CEO said, "We are excited about the opportunity of partnering with EndoChoice to accelerate the adoption of our technology by gastroenterologists.  Our eXaIBD™ and eXaIBS™ tests have both high sensitivity and accuracy, helping to identify IBD and IBS from other diseases, avoiding an extensive series of exclusionary testing."

"EndoChoice is focused on satisfying the unmet needs of GI professionals by delivering innovative, best-in-class products and services," said Mark Gilreath, EndoChoice's CEO.  "We are pleased to offer Exagen's proprietary eXaIBD™ and eXaIBS™ tests because they provide a superior diagnostic tool to assist gastroenterologists and improve patient care."

About Exagen Diagnostics, Inc.

Exagen Diagnostics is the emerging leader in laboratory-discovered and developed genomic tests specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. Using Coperna®, the company's proprietary, algorithm-driven computational tool and search engine that runs on high-performance computational clusters, it combines the ability to process massive amounts of data contained in genomic datasets with intelligent, rapid search methods. Coperna's targeted and precise discovery model has no conventional equivalent in the molecular diagnostics industry as it can identify relevant marker sets with superior sensitivity and specificity relative to markers identified via traditional analytical methods. For more information, please visit www.exagen.com.

About EndoChoice, Inc.

EndoChoice delivers innovative solutions to professionals in gastrointestinal endoscopy with its diverse portfolio of high-quality diagnostics, equipment, devices, supplies and services.   The company strives to cleverly exceed its customers' expectations through its nationwide sales force, exemplary customer care, superior products and easy online ordering.  For more information, visit www.endochoice.com.

SOURCE Exagen Diagnostics, Inc.

RELATED LINKS
http://www.exagen.com
http://www.endochoice.com

'/>"/>

SOURCE Exagen Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Scott Glenn Joins Exagen Diagnostics as Chairman and CEO
2. AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments
3. Sword Diagnostics Announces Availability of Proprietary Detection Technology for Ultrasensitive Immunoassays.
4. Inverness Medical Innovations Offers to Acquire Standard Diagnostics
5. Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics
6. Fujirebio Diagnostics Named Life Sciences Company of the Year
7. U.S. Patent Office Issues Sword Diagnostics Patent for Highly Sensitive Immunodetection Technology
8. Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation
9. Roche Diagnostics Opens State-of-the-Art Training Center in California
10. Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition
11. Reportlinker Adds Molecular Diagnostics - A World Market Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 2016 , ... TherapySites, the leading website and ... Tennessee Counseling Association. This new relationship allows TherapySites to continue to extend ... exclusive benefits and promotional offers. , "TCA is extremely excited about this new ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
Breaking Medicine News(10 mins):